Skip to main content

Table 3 Relative odds of post-anti-thymocyte globulin febrile complications according to procalcitonin concentration on transplantation day

From: Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study

 

Quartile of procalcitonin concentration

(range, μg/L)

 

Q1

(<1.6)

Q2

(1.6–4.1)

Q3

(4.1–14.9)

Q4

(>183)

P trend

Crude matched pairs

     

   OR

1.00

1.10

1.05

1.10

0.095

   95% CI

-

0.03–0.85

0.25–5.87

2.51–59.87

 

   P value

-

0.26

0.11

0.09

 

Adjusted for C-reactive protein

     

   OR

1.0

1.08

1.10

1.07

0.123

   95% CI

-

0.026–0.99

0.31–5.75

2.41–58.35

 

   P value

-

0.34

0.10

0.09

 
  1. The relative odds of post-anti-thymocyte globulin (ATG) febrile/infectious complications did not increase significantly with each increasing quartile of baseline procalcitonin concentration, so patients in the highest versus lowest quartile did not have any increase in risk. After adjustment for C-reactive protein, the concentration of procalcitonin remained unassociated with the risk of post-ATG febrile complications. CI, confidence interval; OR, odds ratio.
Back to article page

Critical Care

ISSN: 1364-8535